These data are in agreement with previous findings indicating that upon BRAF inhibition, melanoma-associated fibroblasts provide melanoma cells with drug tolerance [32], and co-culturing of melanoma cells with fibroblasts in vitro conveys protection to the growth inhibitory effects of the BRAF inhibitor vemurafenib [33]. The gene discussed is BRAF; the disease is melanoma.